User profiles for Jacqueline Miot
Jacqui MiotHealth Economics and Epidemiology Research Office, University of Witwatersrand Verified email at heroza.org Cited by 875 |
[HTML][HTML] Medicines regulation in Africa: current state and opportunities
M Ndomondo-Sigonda, J Miot, S Naidoo… - Pharmaceutical …, 2017 - Springer
Sound regulatory systems are critical for protecting public health against use of medical
products which do not meet international standards of quality, safety and efficacy. This review …
products which do not meet international standards of quality, safety and efficacy. This review …
The African medicines regulatory harmonization initiative: progress to date
M Ndomondo-Sigonda, J Miot, S Naidoo… - Medical Research …, 2018 - esmed.org
The African Medicines Regulatory Harmonization Initiative (AMRH) has contributed to reduce
marketing authorization timelines in East African Community and the Southern African …
marketing authorization timelines in East African Community and the Southern African …
[HTML][HTML] Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community
Background Limited capacity to regulate medical products is associated with circulation of
products which do not meet standards of quality, safety and efficacy with negative public …
products which do not meet standards of quality, safety and efficacy with negative public …
Community health worker models in South Africa: a qualitative study on policy implementation of the 2018/19 revised framework
…, S Mngadi, N Ngcobo, J Miot… - Health Policy and …, 2021 - academic.oup.com
South Africa has a long history of community health workers (CHWs). It has been a journey
that has required balancing constrained resources and competing priorities. CHWs form a …
that has required balancing constrained resources and competing priorities. CHWs form a …
[HTML][HTML] A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa
The Global Action Plan on antimicrobial resistance calls for the use of antimicrobial
medicines in human and animal health to be optimized, in tandem with a strengthening of the …
medicines in human and animal health to be optimized, in tandem with a strengthening of the …
[HTML][HTML] Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
Background In response to the global pandemic of COVID-19, countries around the world
began imposing stay-at-home orders, restrictions on transport, and closures of businesses in …
began imposing stay-at-home orders, restrictions on transport, and closures of businesses in …
[HTML][HTML] Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts
HIV treatment programs face challenges in identifying patients at risk for loss-to-follow-up
and uncontrolled viremia. We applied predictive machine learning algorithms to anonymised, …
and uncontrolled viremia. We applied predictive machine learning algorithms to anonymised, …
[HTML][HTML] Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa
J Miot, M Wagner, H Khoury, D Rindress… - Cost Effectiveness and …, 2012 - Springer
Background Systematic and transparent approaches to priority setting are needed,
particularly in low-resource settings, to produce decisions that are sound and acceptable to …
particularly in low-resource settings, to produce decisions that are sound and acceptable to …
Introducing health technology assessment in Tanzania
ObjectivesHealth technology assessment (HTA) is a cost-effective resource allocation tool
in healthcare decision-making processes; however, its use is limited in low-income settings …
in healthcare decision-making processes; however, its use is limited in low-income settings …
[HTML][HTML] National medicines regulatory authorities financial sustainability in the East African Community
M Ndomondo-Sigonda, J Miot, S Naidoo, B Ng'andu… - PLoS …, 2020 - journals.plos.org
Introduction Adequate and sustainable funding of national medicine regulatory agencies (NMRAs)
is key for assurance of quality, safety and efficacy of medical products circulating in a …
is key for assurance of quality, safety and efficacy of medical products circulating in a …